hh.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden: individual data from national registers
Högskolan i Halmstad, Sektionen för hälsa och samhälle (HOS), Centrum för forskning om välfärd, hälsa och idrott (CVHI).
Nordiska Högskolan för folkhälsovetenskap, Göteborg, Sverige.
Nordiska Högskolan för folkhälsovetenskap, Göteborg, Sverige.
2008 (Engelska)Ingår i: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 17, nr 1, s. 37-42Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

PURPOSE: To determine the prevalence of purchase of prescribed antihypertensive and/or serum lipid-reducing pharmaceutical preparations among different age groups, from the age of 45, in the Swedish population. Further, to calculate the percentage of the population, from the age of 60, who purchased these pharmaceuticals without having had a circulatory diagnosis in the Hospital Discharge Register the last 7 years, or having purchased nitrate vasodilators, as an attempt to estimate the proportion of primary preventive treatments. METHODS: A cross-sectional study, of individual data on prescriptions for antihypertensives (C02-C03, C07-C09) and serum lipid-reducing agents (C10), dispensed from July to December 2005 for the Swedish population. Data were obtained from the new Swedish Prescribed Drugs Register. The data were related to population statistics, and linked to data on diagnoses of cardiovascular disease (I00-I99), from the Swedish Hospital Discharge Register 1998-2004. Data on individuals with purchase of antihypertensive or serum lipid-reducing agents, but without a diagnosis of cardiovascular disease, were also linked to purchase of nitrate vasodilators (C01D). RESULTS: Among Swedes of 60 years and above, 53% purchased antihypertensive or serum lipid-reducing pharmaceuticals, and 30% purchased the pharmaceuticals without having been hospitalized for a coronary or cerebrovascular event during the previous 7 years, or having purchased prescribed nitrate vasodilators during 6 months. CONCLUSION: Over half of the Swedish senior population purchased prescribed antihypertensive or serum lipid-reducing drugs during 6 months in 2005. The magnitude of the prevalence points to the importance of intensified follow-up of both adverse effects and of effectiveness of these drugs.

Ort, förlag, år, upplaga, sidor
Chichester, West Sussex: John Wiley & Sons, 2008. Vol. 17, nr 1, s. 37-42
Nyckelord [en]
age distribution, antihypertensive agents, antilipemic agents, beta adrenergic receptor blocking agent, calcium channel blocking agent, cardiovascular diseases, cerebrovascular disease, COA reductase inhibitors, coronary artery disease, cross-sectional studies, diuretic agent, drug prescriptions, drug prevalence, drug use, drug utilization, elderly, major clinical study, nitrates, physician's practice patterns, prescription, prevalence, primary health care, primary prevention, priority journal, register, registries, serum lipid-reducing, Sweden, unspecified side effect, vasodilator agents
Nationell ämneskategori
Farmaceutiska vetenskaper
Identifikatorer
URN: urn:nbn:se:hh:diva-5100DOI: 10.1002/pds.1515ISI: 000252535300005PubMedID: 17987590Scopus ID: 2-s2.0-38649098186OAI: oai:DiVA.org:hh-5100DiVA, id: diva2:328120
Tillgänglig från: 2010-07-01 Skapad: 2010-07-01 Senast uppdaterad: 2018-03-23Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Silwer, Louise

Sök vidare i DiVA

Av författaren/redaktören
Silwer, Louise
Av organisationen
Centrum för forskning om välfärd, hälsa och idrott (CVHI)
I samma tidskrift
Pharmacoepidemiology and Drug Safety
Farmaceutiska vetenskaper

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 36 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf